Regional genome transcriptional response of adult mouse brain to hypoxia

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Xu, Huichun ^a,b   Lu, Aigang ^c   Sharp, Frank R ^b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYPOXIA INDUCIBLE FACTOR; RETINOID X RECEPTOR; SOMATOMEDIN; CALCITRIOL RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN FUNCTION; BRAIN HYPOXIA; BRAIN REGION; CELL SURVIVAL; CEREBELLUM; COGNITION; CONTROLLED STUDY; DOWN REGULATION; FOREBRAIN; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REOXYGENATION; RHOMBENCEPHALON; UPREGULATION; ANIMAL; ANOXIA; BRAIN; C57BL MOUSE; GENETICS; GENOME; METABOLISM; PROMOTER REGION; TIME;

ANIMALS; ANOXIA; BINDING SITES; BRAIN; CEREBELLUM; GENOME; HEPATOCYTE NUCLEAR FACTOR 4; HIPPOCAMPUS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; RETINOID X RECEPTORS; TIME FACTORS; TRANSCRIPTOME; UP-REGULATION;

EID: 80053647088     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-499     Document Type: Article

References (60)

1. Bernaudin M, Tang Y, Reilly M, Petit E, Sharp FR. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 2002, 277(42):39728-39738. 10.1074/jbc.M204619200, 12145288.
2. Tang Y, Pacary E, Freret T, Divoux D, Petit E, Schumann-Bard P, Bernaudin M. Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: Identification of potential neuroprotective candidates for stroke. Neurobiology of Disease 2006, 21(1):18-28. 10.1016/j.nbd.2005.06.002, 16040250.
3. Gidday JM, Fitzgibbons JC, Shah AR, Park TS. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 1994, 168(1-2):221-224. 10.1016/0304-3940(94)90455-3, 8028780.
4. Sharp FR, Ran R, Lu A, Tang Y, Strauss KI, Glass T, Ardizzone T, Bernaudin M. Hypoxic preconditioning protects against ischemic brain injury. NeuroRx 2004, 1(1):26-35. 10.1602/neurorx.1.1.26, 534910, 15717005.
5. Ran R, Xu H, Lu A, Bernaudin M, Sharp FR. Hypoxia preconditioning in the brain. Dev Neurosci 2005, 27(2-4):87-92. 10.1159/000085979, 16046841.
6. Miller BA, Perez RS, Shah AR, Gonzales ER, Park TS, Gidday JM. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 2001, 12(8):1663-1669. 10.1097/00001756-200106130-00030, 11409736.
7. Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006, 7(6):437-448.
8. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 2002, 22(4):393-403.
9. Gustavsson M, Wilson MA, Mallard C, Rousset C, Johnston MV, Hagberg H. Global gene expression in the developing rat brain after hypoxic preconditioning: involvement of apoptotic mechanisms?. Pediatr Res 2007, 61(4):444-450. 10.1203/pdr.0b013e3180332be4, 17515869.
10. Jones NM, Kardashyan L, Callaway JK, Lee EM, Beart PM. Long-term functional and protective actions of preconditioning with hypoxia, cobalt chloride, and desferrioxamine against hypoxic-ischemic injury in neonatal rats. Pediatr Res 2008, 63(6):620-624. 10.1203/PDR.0b013e31816d9117, 18317402.
11. Gage AT, Stanton PK. Hypoxia triggers neuroprotective alterations in hippocampal gene expression via a heme-containing sensor. Brain Res 1996, 719(1-2):172--178. 10.1016/0006-8993(96)00092-3, 8782877.
12. Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 2002, 22(15):6401-6407.
13. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982, 11(5):491-498. 10.1002/ana.410110509, 7103425.
14. Cervos-Navarro J, Diemer NH. Selective vulnerability in brain hypoxia. Crit Rev Neurobiol 1991, 6(3):149-182.
15. Cimarosti H, Jones NM, O'Shea RD, Pow DV, Salbego C, Beart PM. Hypoxic preconditioning in neonatal rat brain involves regulation of excitatory amino acid transporter 2 and estrogen receptor alpha. Neurosci Lett 2005, 385(1):52-57. 10.1016/j.neulet.2005.05.006, 15927375.
16. Wenger RH, Stiehl DP, Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005, 2005(306):re12..
17. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 2003, 362(9389):1028-1037. 10.1016/S0140-6736(03)14412-1, 14522533.
18. Lu A, Tang Y, Ran R, Clark JF, Aronow BJ, Sharp FR. Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab 2003, 23(7):786-810.
19. Sarabi AS, Shen H, Wang Y, Hoffer BJ, Backman CM. Gene expression patterns in mouse cortical penumbra after focal ischemic brain injury and reperfusion. J Neurosci Res 2008, 86(13):2912-2924. 10.1002/jnr.21734, 18506852.
20. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004, 303(5662):1378-1381. 10.1126/science.1089769, 3012624, 14988562.
21. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004, 101(16):6062-6067. 10.1073/pnas.0400782101, 395923, 15075390.
22. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 2000, 48(3):285-296. 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8, 10976634.
23. Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, Victorov I, Kapinya K, Dirnagl U, Meisel A. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 2003, 34(8):1981-1986. 10.1161/01.STR.0000080381.76409.B2, 12829864.
24. Englander EW, Greeley GH, Wang G, Perez-Polo JR, Lee HM. Hypoxia-induced mitochondrial and nuclear DNA damage in the rat brain. J Neurosci Res 1999, 58(2):262-269. 10.1002/(SICI)1097-4547(19991015)58:2<262::AID-JNR6>3.0.CO;2-W, 10502282.
25. Risom L, Lundby C, Thomsen JJ, Mikkelsen L, Loft S, Friis G, Moller P. Acute hypoxia and reoxygenation-induced DNA oxidation in human mononuclear blood cells. Mutat Res 2007, 625(1-2):125-133. 10.1016/j.mrfmmm.2007.06.001, 17644143.
26. Helton ES, Chen X. p53 modulation of the DNA damage response. J Cell Biochem 2007, 100(4):883-896. 10.1002/jcb.21091, 17031865.
27. Jones NM, Bergeron M. Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J Neurochem 2004, 89(1):157-167. 10.1111/j.1471-4159.2004.02324.x, 15030400.
28. Liu J, Narasimhan P, Yu F, Chan PH. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin. Stroke 2005, 36(6):1264-1269. 10.1161/01.STR.0000166180.91042.02, 15890996.
29. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004, 57(10):1009-1014. 10.1136/jcp.2003.015032, 1770458, 15452150.
30. Halterman MW, Miller CC, Federoff HJ. Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci 1999, 19(16):6818-6824.
31. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, et al. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 2005, 25(16):4099-4107. 10.1523/JNEUROSCI.4555-04.2005, 15843612.
32. Piret JP, Mottet D, Raes M, Michiels C. Is HIF-1alpha a pro- or an anti-apoptotic protein?. Biochem Pharmacol 2002, 64(5-6):889-892. 10.1016/S0006-2952(02)01155-3, 12213583.
33. Datson NA, Morsink MC, Meijer OC, de Kloet ER. Central corticosteroid actions: Search for gene targets. Eur J Pharmacol 2008, 583(2-3):272-289. 10.1016/j.ejphar.2007.11.070, 18295201.
34. Furay AR, Bruestle AE, Herman JP. The role of the forebrain glucocorticoid receptor in acute and chronic stress. Endocrinology 2008, 149(11):5482-5490. 10.1210/en.2008-0642, 2584591, 18617609.
35. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 1997, 504(Pt 1):241-249. 1159952, 9350634.
36. Moncloa F, Donayre J, Sobrevilla LA, Guerra-Garcia R. Endocrine studies at high altitude. II. Adrenal cortical function in sea level natives exposed to high altitudes (4300 metersfor two weeks. J Clin Endocrinol Metab 1965, 25(12):1640-1642. 10.1210/jcem-25-12-1640, 5845863.
37. Kodama T, Shimizu N, Yoshikawa N, Makino Y, Ouchida R, Okamoto K, Hisada T, Nakamura H, Morimoto C, Tanaka H. Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. J Biol Chem 2003, 278(35):33384-33391. 10.1074/jbc.M302581200, 12810720.
38. Johnson TS, Rock PB, Fulco CS, Trad LA, Spark RF, Maher JT. Prevention of acute mountain sickness by dexamethasone. N Engl J Med 1984, 310(11):683-686. 10.1056/NEJM198403153101103, 6700643.
39. Harms C, Albrecht K, Harms U, Seidel K, Hauck L, Baldinger T, Hubner D, Kronenberg G, An J, Ruscher K, et al. Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci 2007, 27(17):4562-4571. 10.1523/JNEUROSCI.5110-06.2007, 17460069.
40. Lu XC, Williams AJ, Yao C, Berti R, Hartings JA, Whipple R, Vahey MT, Polavarapu RG, Woller KL, Tortella FC, et al. Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J Neurosci Res 2004, 77(6):843-857. 10.1002/jnr.20218, 15334602.
41. Harper RM. The cerebellum and respiratory control. Cerebellum 2002, 1(1):1-2.
42. Nisimaru N. Cardiovascular modules in the cerebellum. Jpn J Physiol 2004, 54(5):431-448. 10.2170/jjphysiol.54.431, 15667667.
43. Pena F, Ramirez JM. Hypoxia-induced changes in neuronal network properties. Mol Neurobiol 2005, 32(3):251-283. 10.1385/MN:32:3:251, 16385141.
44. Reis DJ, Golanov EV, Galea E, Feinstein DL. Central neurogenic neuroprotection: central neural systems that protect the brain from hypoxia and ischemia. Ann N Y Acad Sci 1997, 835:168-186. 10.1111/j.1749-6632.1997.tb48628.x, 9616772.
45. Reis DJ, Berger SB, Underwood MD, Khayata M. Electrical stimulation of cerebellar fastigial nucleus reduces ischemic infarction elicited by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 1991, 11(5):810-818. 10.1038/jcbfm.1991.139, 1874812.
46. Reis DJ, Kobylarz K, Yamamoto S, Golanov EV. Brief electrical stimulation of cerebellar fastigial nucleus conditions long-lasting salvage from focal cerebral ischemia: conditioned central neurogenic neuroprotection. Brain Res 1998, 780(1):161-165. 10.1016/S0006-8993(97)01017-2, 9497093.
47. Zhou P, Qian L, Glickstein SB, Golanov EV, Pickel VM, Reis DJ. Electrical stimulation of cerebellar fastigial nucleus protects rat brain, in vitro, from staurosporine-induced apoptosis. J Neurochem 2001, 79(2):328-338.
48. Galea E, Glickstein SB, Feinstein DL, Golanov EV, Reis DJ. Stimulation of cerebellar fastigial nucleus inhibits interleukin-1beta-induced cerebrovascular inflammation. Am J Physiol 1998, 275(6 Pt 2):H2053-2063.
49. Rollins S, Chen B, Golanov E. Possible role of cerebellar fastigial nucleus in preconditioned neuroprotection. J Cereb Blood Flow Metab 2005, 25(S1):S303-S303.
50. Sladek FM, Zhong WM, Lai E, Darnell JE. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990, 4(12B):2353-2365. 10.1101/gad.4.12b.2353, 2279702.
51. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996, 384(6608):458-460. 10.1038/384458a0, 8945471.
52. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA 2006, 103(22):8419-8424. 10.1073/pnas.0600246103, 1482507, 16714383.
53. Tsuchiya T, Kominato Y, Ueda M. Human hypoxic signal transduction through a signature motif in hepatocyte nuclear factor 4. J Biochem 2002, 132(1):37-44.
54. Zhang W, Tsuchiya T, Yasukochi Y. Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia. J Hum Genet 1999, 44(5):293-299. 10.1007/s100380050163, 10496070.
55. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19(3):368-375. 10.1093/bioinformatics/btf877, 12584122.
56. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445(7124):168-176. 10.1038/nature05453, 17151600.
57. Butler JE, Kadonaga JT. The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 2002, 16(20):2583-2592. 10.1101/gad.1026202, 12381658.
58. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21(13):2933-2942. 10.1093/bioinformatics/bti473, 15860560.
59. Benos PV, Lapedes AS, Stormo GD. Probabilistic code for DNA recognition by proteins of the EGR family. J Mol Biol 2002, 323(4):701-727. 10.1016/S0022-2836(02)00917-8, 12419259.
60. Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci USA 2002, 99(13):8467-8472. 10.1073/pnas.132268899, 124275, 12077306.